Accendra Health Inc (ACH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | -53,799 | -21,886 | -41,301 | N/A |
| Depreciation Amortization | N/A | 137,974 | 74,095 | 210,371 | N/A |
| Income taxes - deferred | N/A | -9,029 | -3,659 | -6,004 | N/A |
| Accounts receivable | N/A | -68,118 | -74,963 | -8,991 | N/A |
| Accounts payable and accrued liabilities | N/A | 203,371 | 52,926 | 5,245 | N/A |
| Other Working Capital | N/A | -3,575 | -95,927 | 137,377 | N/A |
| Other Operating Activity | 3,297,133 | -143,637 | 16,452 | 444,013 | 2,817,566 |
| Operating Cash Flow | $3,297,133 | $63,187 | $-52,962 | $740,710 | $2,817,566 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -845,794 | -23,353 | 3,541 | -100,801 | -586,916 |
| Net Acquisitions | 47,182 | N/A | N/A | N/A | 743 |
| Purchase Of Investment | -409,969 | N/A | N/A | N/A | -833,755 |
| Sale Of Investment | 1,026,536 | N/A | N/A | N/A | 524,780 |
| Purchase Sale Intangibles | N/A | -4,829 | -3,411 | -6,156 | N/A |
| Other Investing Activity | 20,606 | -13,687 | -5,411 | -36,453 | 82,737 |
| Investing Cash Flow | $-161,438 | $-37,040 | $-1,870 | $-137,254 | $-812,411 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,242,251 | 667,300 | 205,000 | 476,000 | 1,964,799 |
| Debt Repayment | -3,136,724 | -679,675 | -143,925 | -892,693 | -3,447,134 |
| Dividend Paid | -739,763 | N/A | N/A | N/A | -426,975 |
| Other Financing Activity | -55,231 | -12,545 | -7,755 | -637 | -144,340 |
| Financing Cash Flow | $-2,689,467 | $-24,920 | $53,320 | $-417,330 | $-2,053,649 |
| Exchange Rate Effect | -13,699 | -682 | -618 | 613 | 1,663 |
| Beginning Cash Position | 2,574,159 | 272,924 | 272,924 | 86,185 | 2,322,384 |
| End Cash Position | 3,006,688 | 273,469 | 270,794 | 272,924 | 2,275,552 |
| Net Cash Flow | $432,529 | $545 | $-2,130 | $186,739 | $-46,832 |
| Free Cash Flow | |||||
| Operating Cash Flow | 3,297,133 | 63,187 | -52,962 | 740,710 | 2,817,566 |
| Capital Expenditure | -912,427 | -90,379 | -45,997 | -172,375 | -588,783 |
| Free Cash Flow | 2,384,706 | -27,192 | -98,959 | 568,335 | 2,228,783 |